CalciMedica is trading at $0.89 (6.3% down) as the stock faces profit-taking pressure following a short-lived rally driven by a board expansion.
- The stock surged on July 9, 2026, following the announcement of the appointment of Evgeny Zaytsev to the board of directors.
- Selling pressure intensified during after-hours trading as investors moved to lock in gains, with the downward momentum carrying into today's regular session.